Chemplast Sanmar Limited announced its unaudited financial results for the quarter and nine months ended December 31, 2025, revealing challenging operational performance across both standalone and consolidated operations. The board of directors approved these results at their meeting held on February 7, 2026, which commenced at 11:45 AM and concluded at 2:00 PM. Subsequently, the company published these results in newspapers on February 8, 2026, and released an investor presentation highlighting key performance metrics.

Financial Performance Overview

The company's consolidated operations showed significant revenue decline during Q3 FY26, with total revenue dropping to ₹835.14 crores compared to ₹1,057.55 crores in the previous year. The nine-month performance also reflected challenges with consolidated revenue at ₹2,968.24 crores against ₹3,195.19 crores in the corresponding period last year.

Investor Presentation Release

On February 8, 2026, at 4:19 PM IST, the company released its investor presentation titled "Performance Highlights - Q3 & 9M FY'26". The presentation is available on the company's website at www.chemplastsanmar.com and provides comprehensive insights into the quarterly and nine-month performance across various business segments.

Business Segment Performance

The investor presentation highlighted performance across key business divisions including PVC operations, Custom Manufactured Chemicals Division (CMCD), and Value-added Chemicals (VAC). The Suspension PVC business faced difficult operating conditions due to weather-related disruptions and lower import prices, while Paste PVC demand remained relatively stable with ongoing anti-dumping duty proceedings.

Management Commentary and Outlook

Managing Director Ramkumar Shankar acknowledged the challenging quarter while emphasizing the company's focus on disciplined execution and cost control. The presentation noted positive developments including Chinese government's decision to withdraw Suspension PVC export tax rebate effective April 2026, which is expected to improve pricing dynamics.

Regulatory Compliance

The financial results and investor presentation comply with SEBI regulations, with Company Secretary M Raman ensuring proper disclosure to stock exchanges. The results were prepared in accordance with Indian Accounting Standard 34 and reviewed by statutory auditors B S R & Co. LLP.

The company continues to progress on strategic initiatives including capacity expansion projects, with MPB-3 Phase 3 and MPB-4 civil works expected to complete in Q4 FY26 and Q1 FY27 respectively.

Chemplast Sanmar Limited's Board of Directors has approved a comprehensive leadership transition plan during its meeting held on January 10, 2026. The decisions, made following recommendations from the Nomination and Remuneration Committee, include key changes in the Managing Director position and the reappointment of independent directors.

Managing Director Transition

The board approved a structured transition for the Managing Director role, addressing the current MD's desire to step down at the end of the financial year.

Ramkumar Shankar, who has served as Managing Director since February 1, 2021, expressed his desire to be relieved from the position at the close of the current financial year 2025-26. To ensure continuity, the board reappointed him for an additional two months from February 1, 2026, to March 31, 2026.

New Managing Director Appointment

S Ganeshkumar will assume the role of Managing Director for three years starting April 1, 2026. The 57-year-old executive brings extensive experience from his current role as CEO and Managing Director of TCI Sanmar Chemicals S.A.E., Egypt, since February 23, 2022.

Professional Background

Ganeshkumar's career spans multiple industries and leadership roles:

• Current Role: CEO and Managing Director, TCI Sanmar Chemicals S.A.E., Egypt (2022-present)
• Previous Positions: President and COO, Raymond Limited Lifestyle Business (2020-2022); CEO Global Operations, JK Files (India) Limited (2016-2020)
• Earlier Experience: Managing Director, Arysta Life Science India Limited (2013-2016); Director, Mosaic India Private Limited (2002-2013)

Independent Directors Reappointment

The board approved the reappointment of four independent directors for their second consecutive five-year terms, effective April 26, 2026.

Key Director Profiles

Aditya Jain (65 years) serves as Chairman of the Nomination and Remuneration Committee, Stakeholders Relationship Committee, and Risk Management Committee. He is the Chairman and Editorial Director of IMA India, an economic and business research company he established in 1994.

Sanjay Vijay Bhandarkar (57 years) brings over three decades of corporate finance and investment banking experience. He previously led Rothschild India's business and currently serves on the boards of major listed companies including Tata Consultancy Services Limited and The Tata Power Company Limited.

Dr Lakshmi Vijayakumar (70 years) is the founder of SNEHA, an NGO for suicide prevention, and serves as Head of Department of Psychiatry at Voluntary Health Services, Chennai. She is a member of WHO's International Network for Suicide Research and Prevention.

Prasad Raghava Menon (79 years) holds a B.Tech in Chemical Engineering from IIT Kharagpur and brings over 50 years of experience across chemical and power industries, including leadership roles at ICI India, Tata Chemicals, and Tata Power.

Meeting Details and Compliance

The board meeting commenced at 11:30 AM and concluded at 12:10 PM on January 10, 2026. All appointed directors have confirmed they are not debarred from holding directorship by SEBI, Ministry of Corporate Affairs, or any other regulatory authority. The appointments are subject to shareholder approval and other required regulatory approvals.